PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Goldhaber, Samuel Z.
TI  - Extended Apixaban Failed to Reduce VTE Risk in Medically Ill Patients
DP  - 2011  01
TA  - MD Conference Express
PG  - 12--13
VI  - 11
IP  - 15
4099  - http://mdc.sagepub.com/content/11/15/12.2.short
4100  - http://mdc.sagepub.com/content/11/15/12.2.full
AB  - An extended course of thromboprophylaxis with apixaban did not reduce the risk of venous thromboembolism (VTE, which consists of pulmonary embolism and deep venous thrombosis) and VTE-related death in medically ill patients compared with a shorter course of enoxaparin, according to findings from the Apixaban Dosing to Optimize Protection from Thrombosis trial [ADOPT; NCT00457002].